Confirmation of Putative HIV-1 Group P in Cameroon

被引：89
|
作者：
Vallari, Ana
Holzmayer, Vera
Harris, Barbara
Yamaguchi, Julie
Ngansop, Charlotte [2 ]
Makamche, Florence [2 ]
Mbanya, Dora [2 ]
Kaptue, Lazare [2 ,3 ]
Ndembi, Nicaise [2 ,4 ]
Guertler, Lutz [5 ]
Devare, Sushil
Brennan, Catherine A. [1 ]
机构：
[1] Abbott Diagnost, Dept 09NG, Abbott Pk, IL 60064 USA
[2] Univ Yaounde 1, Yaounde, Cameroon
[3] Univ Montagnes, Bangangte, Cameroon
[4] Inst Human Virol, Abuja, Nigeria
[5] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany
来源：
JOURNAL OF VIROLOGY | 2011年 / 85卷 / 03期
关键词：
IMMUNODEFICIENCY VIRUSES; GROUP-O; GROUP N; IDENTIFICATION; PREVALENCE; GORILLAS;
D O I：
10.1128/JVI.02005-10
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We report the second human immunodeficiency virus (HIV) belonging to the new HIV type 1 (HIV-1) group P lineage that is closely related to the simian immunodeficiency virus found in gorillas. This virus was identified in an HIV-seropositive male hospital patient in Cameroon, confirming that the group P virus is circulating in humans. Results from screening 1,736 HIV-seropositive specimens collected in Cameroon indicate that HIV-1 group P infections are rare, accounting for only 0.06% of HIV infections. Despite its rarity, group P shows evidence of adaptation to humans.
引用
收藏
页码：1403 / 1407
页数：5
相关论文
共 50 条
  • [31] Prevention of mother to child HIV-1 transmission (MTC) in Cameroon
    Tejiokem, MC
    Nerrienet, E
    Tene, G
    Menu, E
    Barré-Sinoussi, F
    Ayouba, A
    MEDECINE ET MALADIES INFECTIEUSES, 2004, 34 : S57 - S60
  • [32] HIV-1 GROUP-O
    SORIANO, V
    GUTIERREZ, M
    MEDICINA CLINICA, 1995, 105 (13): : 498 - 499
  • [33] Infection with HIV-1 group O
    Gould, K
    AIDS PATIENT CARE AND STDS, 1997, 11 (06) : 399 - 405
  • [34] Reactivity of a new HIV-1 group O third generation A-HIV-1/-2 assay with an unusual HIV-1 seroconversion panel and HIV-1 group O group M subtyped samples
    van Binsbergen, J
    Keur, W
    van der Graaf, M
    Siebelink, A
    Jacobs, A
    de Rijk, D
    Toonen, J
    Zekeng, L
    Ze, EA
    Gurtler, LG
    JOURNAL OF VIROLOGICAL METHODS, 1997, 69 (1-2) : 29 - 37
  • [35] HIV-1 group P infection: towards a dead-end infection?
    Alessandri-Gradt, Elodie
    De Oliveira, Fabienne
    Leoz, Marie
    Lemee, Veronique
    Robertson, David L.
    Feyertag, Felix
    Ngoupo, Paul-Alain
    Mauclere, Philippe
    Simon, Francois
    Plantier, Jean-Christophe
    AIDS, 2018, 32 (10) : 1317 - 1322
  • [36] Inaccurate Diagnosis of HIV-1 Group M and O Is a Key Challenge for Ongoing Universal Access to Antiretroviral Treatment and HIV Prevention in Cameroon
    Aghokeng, Avelin F.
    Mpoudi-Ngole, Eitel
    Dimodi, Henriette
    Atem-Tambe, Arrah
    Tongo, Marcel
    Butel, Christelle
    Delaporte, Eric
    Peeters, Martine
    PLOS ONE, 2009, 4 (11):
  • [37] Detection of HIV-1 Group M non-B subtypes and HIV-1 Group O specimens with a modified recombinant HIV-1/HIV-2 enzyme immunoassay
    Stephens, JE
    Falcon, B
    Gallarda, J
    Motley, C
    Newton, J
    Peterson, MB
    Skora, C
    Devare, S
    Vallari, A
    Brennan, C
    Swanson, P
    TRANSFUSION, 1997, 37 (09) : S179 - S179
  • [38] Engineering chemokines to develop putative anti HIV-1 agents
    A Deepu
    A Aravind
    K Santhosh Kumar
    BMC Infectious Diseases, 12 (Suppl 1)
  • [39] A catalogue of putative HIV-1 protease host cell substrates
    Impens, Francis
    Timmerman, Evy
    Staes, An
    Moens, Kathleen
    Arien, Kevin K.
    Verhasselt, Bruno
    Vandekerckhove, Joel
    Gevaert, Kris
    BIOLOGICAL CHEMISTRY, 2012, 393 (09) : 915 - 931
  • [40] EVALUATION OF DIFFERENT SUPPLEMENTARY ASSAYS FOR THE CONFIRMATION OF HIV-1 AND HIV-2 INFECTIONS
    SORIANO, V
    GUTIERREZ, M
    HEREDIA, A
    BRAVO, R
    HEWLETT, I
    GONZALEZLAHOZ, J
    VOX SANGUINIS, 1994, 66 (01) : 82 - 83
12345